Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
Abstract Background To support public health measures during the COVID-19 pandemic, oral opioid agonist treatment (OAT) take-home doses were expanded in Western countries with positive results. Injectable OAT (iOAT) take-home doses were previously not an eligible option, and were made available for...
Збережено в:
Автори: | , , , , , , , , , , , |
---|---|
Формат: | Книга |
Опубліковано: |
BMC,
2023-05-01T00:00:00Z.
|
Предмети: | |
Онлайн доступ: | Connect to this object online. |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Примірник 1 | Доступно |